Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Raloxifene”

65 trials

Showing 20 of 65 results

Post-approval studies (Phase 4)Active Not RecruitingNCT03623633
What this trial is testing

Comparative Antiresorptive Efficacy Discontinuation of Denosumab

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Massachusetts General Hospital 51
Large-scale testing (Phase 3)Study completedNCT05172050
What this trial is testing

Multicenter Double Blind, Parallel-group Phase 2/3 Trial, to Study Raloxifene in Adult COVID-19 Patients.

Who this might be right for
SARS CoV 2 Infection
Dompé Farmaceutici S.p.A 61
Testing effectiveness (Phase 2)Study completedNCT00001848
What this trial is testing

The Safety and Effectiveness of Surgery With or Without Raloxifene for the Treatment of Pelvic Pain Caused by Endometriosis

Who this might be right for
EndometriosisPelvic Pain
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 612
Not applicableEnded earlyNCT00847821
What this trial is testing

Observational Study Analyzing RNA Expression Of Endometrial Biopsy Samples From Placebo, Bazedoxifene/Conjugated Estrogens And Raloxifene

Who this might be right for
Postmenopause
Wyeth is now a wholly owned subsidiary of Pfizer 185
Post-approval studies (Phase 4)Study completedNCT00371956
What this trial is testing

Raloxifene for Prevention of Bone Loss in Postmenopausal Patients Receiving Chronic Corticosteroid Therapy

Who this might be right for
Osteoporosis
Tuen Mun Hospital 114
Large-scale testing (Phase 3)Study completedNCT00190593
What this trial is testing

Raloxifene Use for The Heart

Who this might be right for
Cardiovascular DiseasesBreast Neoplasms
Eli Lilly and Company 10,000
Not applicableStudy completedNCT00200174
What this trial is testing

Combined Estrogen Blockade of the Breast With Exemestane and Raloxifene in Postmenopausal Women With a History of Breast Cancer Who Have No Clinical Evidence of Disease

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 11
Not applicableStudy completedNCT00031850
What this trial is testing

Raloxifene and Goserelin in Preventing Breast Cancer in Women With a Family History of Breast Cancer

Who this might be right for
Breast Cancer
Institute of Cancer Research, United Kingdom 150
Early research (Phase 1)Study completedNCT02654093
What this trial is testing

A Drug-drug Interaction Study of DP-R213

Who this might be right for
Healthy
Alvogen Korea 24
Large-scale testing (Phase 3)Study completedNCT00389740
What this trial is testing

A Comparison Study With Alendronate and Raloxifene in Postmenopausal Women With Osteoporosis (0217-189)

Who this might be right for
Osteoporosis, Postmenopausal
Organon and Co 400
Testing effectiveness (Phase 2)Study completedNCT02517593
What this trial is testing

Genetic Risk Estimation of Breast Cancer Prior to Preventive Medication Uptake

Who this might be right for
Breast Cancer
Mayo Clinic 151
Post-approval studies (Phase 4)Study completedNCT00035971
What this trial is testing

EVA: Evista Alendronate Comparison

Who this might be right for
Osteoporosis
Eli Lilly and Company
Post-approval studies (Phase 4)Study completedNCT02354001
What this trial is testing

Selective Estrogen Receptor Modulators for Women of Child-bearing Age With Schizophrenia

Who this might be right for
SchizophreniaSchizoaffective Disorder
The Alfred 80
Large-scale testing (Phase 3)Study completedNCT00670319
What this trial is testing

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis, Postmenopausal
Eli Lilly and Company 7,705
Not applicableStudy completedNCT04788290
What this trial is testing

An Observational Study Assessing Effects in Patients With Combination Therapy With Raloxifene/Cholecalciferol

Who this might be right for
Osteoporosis
Hanmi Pharmaceutical Company Limited 3,907
Not applicableStudy completedNCT00774267
What this trial is testing

Study Evaluating Changes In Mammographic Breast Density

Who this might be right for
Osteoporosis
Pfizer 507
Not applicableStudy completedNCT02982083
What this trial is testing

Clinical Trial on the Efficacy of Raloxifene on Disease Activity in Rheumatoid Arthritis

Who this might be right for
Rheumatoid Arthritis
Sara Saeidi Shahri 34
Post-approval studies (Phase 4)Study completedNCT01535027
What this trial is testing

Combined Administration of Teripapartide and Antiresorptive Agents in Postmenopausal Osteoporosis

Who this might be right for
Osteoporosis
Medical University of Vienna 125
Large-scale testing (Phase 3)Study completedNCT00427700
What this trial is testing

Induction of Ovulation With Raloxifene or Clomiphene Citrate in Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Hospital de Clinicas de Porto Alegre 82
Testing effectiveness (Phase 2)Study completedNCT00149604
What this trial is testing

AFTER: Altering Fat Through Estrogen and Raloxifene

Who this might be right for
Postmenopause
National Institute on Aging (NIA) 108
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation